Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Surgeons Report Melanoma Recurs After 10 Years in More

28.06.2013
Journal of the American College of Surgeons study author says that patients’ medical follow-up after a melanoma diagnosis should be lifelong

Recurrence of melanoma skin cancer 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study, these patients tend to live longer after their cancer returns than patients whose melanoma recurs in the first three years. The study results appear in the July issue of the Journal of the American College of Surgeons.

“For patients with melanoma, survival beyond 10 years without a recurrence has been considered nearly synonymous with a cure,” said principal investigator Mark Faries, MD, FACS, a professor of surgery at the John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA. “However, most studies do not follow up patients longer than 10 years. Our study found that late melanoma recurrence is not rare and that it occurs more frequently in certain patient groups.”

Patients with a higher chance of melanoma—the deadliest form of skin cancer—recurring more than a decade later, compared with early recurrence of melanoma within the first three years, were typically a younger age at initial diagnosis and generally exhibited less serious characteristics of the original tumor, Dr. Faries and colleagues reported.

Dr. Faries said the study represents the largest reported group of melanoma patients with a first recurrence at least a decade later. Of 4,731 patients who were diagnosed with skin melanoma at their medical center and received long-term follow-up, 408 patients experienced a late melanoma recurrence after being disease free 10 or more years, the authors reported.

Recurrence rates using actuarial analysis were reportedly 6.8 percent 15 years after initial treatment and 11.3 percent at 25 years.

When the investigators determined the melanoma recurrence rate by including only patients who received initial treatment at the John Wayne Cancer Institute, they found that 327(6.9 percent) of the 4,731 patients showed a late recurrence.

“It appears the risk of melanoma recurrence is never completely gone,” Dr. Faries said. “One change that should result from our study is that people need to be followed up for life with a physician after a diagnosis of melanoma.”

The American Cancer Society estimates that nearly 76,700 new cases of melanoma will be diagnosed in the U.S. this year according to 2013 estimates, with more men affected than women.*

The new study findings, however, showed that late melanoma recurrence was less male-predominant than in patients whose cancer recurred within the first three years. Although 66 percent of 3,127 patients with an early melanoma recurrence were men, only 57 percent of the 408 patients with a late recurrence were male, the investigators reported. This difference may be because initially “melanoma behaves worse in men than in women, although no one knows why,” he said.

The researchers note other differences existed between patient groups. Namely, patients whose melanoma did not come back until at least 10 years later were younger, on average, than those with an early recurrence: 41 versus 51 years old.

In addition, compared with the early-recurrence group, patients with a late recurrence tended to have had an original melanoma with characteristics indicating a more favorable disease outcome. Specifically, their original tumor was more likely to have been thin and nonulcerated (meaning that the skin over the melanoma had not broken down), not have spread to the lymph nodes, and occurred at a site other than the head and neck.

Although the investigators found that late-recurring melanomas were more likely to develop in a site on the body distant from the original site, this group of patients had a better post-recurrence survival rate. Compared with patients whose cancer returned within three years, patients with a late recurrence were about 40 percent less likely to die of melanoma than were patients with an early recurrence, Dr. Faries said. Overall survival also was better in the late-recurrence group according to the researchers.

“Fortunately, the vast majority of melanoma patients who remain disease free longer than 10 years will not have a recurrence,” Dr. Faries said. “However, patients should be aware that persistent or unexplained symptoms anywhere in the body might indicate a recurrence of their melanoma, and they should return to their physician to make sure the symptoms are not related.”

Even when symptoms are absent, Dr. Faries recommended that patients get an annual clinical examination with their melanoma physician or primary care physician. He also orders a yearly chest X ray and laboratory tests for his melanoma patients.

Other study authors, all from the John Wayne Cancer Institute, included Shawn Steen, MD; Xing Ye; Myung Sim, DrPH; and Donald L. Morton, MD, FACS.

Study researchers received partial support from the National Cancer Institute, Melanoma Research Alliance, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and Alan and Brenda Borstein.

Citation: Journal of the American College of Surgeons, July 2013: Vol 217(1):27-34.

*Source: What are the key statistics about melanoma skin cancer? American Cancer Society. Available at: www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-key-statistics, Accessed June 20, 2013.

About the American College of Surgeons
The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for all surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 79,000 members and is the largest organization of surgeons in the world. For more information, visit www.facs.org.

Dan Hamilton | EurekAlert!
Further information:
http://www.facs.org

More articles from Health and Medicine:

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Massive impact crater from a kilometer-wide iron meteorite discovered in Greenland

15.11.2018 | Earth Sciences

When electric fields make spins swirl

15.11.2018 | Physics and Astronomy

Discovery of a cool super-Earth

15.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>